NewAmsterdam Pharma News

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and NewAmsterdam Pharma Company (NAMS)

TipRanksApr 2 08:30 ET

NewAmsterdam Pharma Analyst Ratings

BenzingaMar 13 17:21 ET

NewAmsterdam Pharma Analyst Ratings

BenzingaFeb 29 12:08 ET

RBC Raises Price Target on NewAmsterdam Pharma to $31 From $25, Keeps Outperform, Speculative Risk

MT NewswiresFeb 29 07:55 ET

Buy Rating Reaffirmed for NewAmsterdam Pharma With Increased Price Target Amid Promising Drug Trials and Strategic Initiatives

TipRanksFeb 27 23:39 ET

Buy Rating on NewAmsterdam Pharma: Underappreciated Potential of Obicetrapib in CVD Market

TipRanksFeb 13 05:12 ET

NewAmsterdam Pharma Analyst Ratings

BenzingaJan 18 07:09 ET

NewAmsterdam Pharma Analyst Ratings

BenzingaJan 16 15:25 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), NewAmsterdam Pharma Company (NAMS) and Marinus (MRNS)

TipRanksJan 9 01:40 ET

Analysts Are Bullish on Top Healthcare Stocks: NewAmsterdam Pharma Company (NAMS), Envista Holdings (NVST)

TipRanksNov 17, 2023 08:11 ET

Promising Financial and Developmental Progress Earns NewAmsterdam Pharma a Buy Rating

TipRanksNov 16, 2023 07:21 ET

RBC Capital Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TipRanksNov 14, 2023 20:47 ET

RBC Capital Initiates Coverage On NewAmsterdam Pharma With Outperform Rating, Announces Price Target of $25

BenzingaOct 30, 2023 06:53 ET

NewAmsterdam Pharma Analyst Ratings

BenzingaOct 30, 2023 06:52 ET

Analysts Are Bullish on These Healthcare Stocks: NewAmsterdam Pharma Company (NAMS), Legend Biotech (LEGN)

TipRanksAug 16, 2023 08:21 ET

Jefferies Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

TipRanksAug 8, 2023 08:25 ET

SVB Securities Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TipRanksJun 9, 2023 09:45 ET

Analysts Are Bullish on These Healthcare Stocks: POINT Biopharma Global (PNT), NewAmsterdam Pharma Company (NAMS)

TipRanksMay 16, 2023 23:20 ET

SVB Securities Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

TipRanksApr 7, 2023 02:50 ET

Credit Suisse Maintains Outperform on NewAmsterdam Pharma, Raises Price Target to $22

BenzingaApr 3, 2023 07:32 ET